| 4Q1C: reference: Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability., Nomme J, Li Z, Gipson RM, Wang J, Armijo AL, Le T, Poddar S, Smith T, Santarsiero BD, Nguyen HA, Czernin J, Alexandrova AN, Jung ME, Radu CG, Lavie A, J Med Chem. 2014 Oct 23. PMID: 25341194 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).